Portland's 5.5-point gap under Maine's rate, rural Cumberland County HPSAs that stop at the city line, Maine Medical Center's specialist concentration, and one local price that is not a total.
Portland's adult obesity prevalence is 27.7% (CDC PLACES 2025 release, BRFSS 2023) 1, running 5.5 points below Maine's statewide 33.2% 2. The state's obesity burden is real; Portland is not where it concentrates.
This is a city of 69,572 inside a 562,843-person metro, 4.4% uninsured, with an $82,059 median household income 34. The gap here is not coverage or supply. It is that of three Portland providers checked, exactly one publishes any number, and even that one is not a total 891011.
Maine expanded MaineCare through a November 2017 voter-approved ballot initiative, with implementation beginning January 10, 2019 and coverage retroactive to July 2018 7.
Whether a specific MaineCare or commercial plan covers a GLP-1 for weight loss, as opposed to a diabetes diagnosis, depends on the individual plan and formulary. No single MaineCare pharmacy or formulary citation was located to pin the weight-loss answer down, so that detail is left here as a data gap rather than a guess.
The Cosmetic Enhancement Center of New England at 1945 Congress St, Building C publishes a membership structure: a $300 one-time enrollment fee plus $150/month covering injection visits, with medication billed separately and described only as varying by dosage 8. A separate page on the same site quotes semaglutide "starting at $450 per month with a 3-month commitment" 9. That is a starting price on top of a membership, before a variable medication cost, and it is the only published number in the city.
Maine Aesthetic Medicine at 163 Fore Street says on its homepage that its weight-loss and GLP-1 program is "launching in 2026" and directs patients to contact the practice for an "exclusive discount" quote; there is no dedicated GLP-1 page and no dollar figure anywhere in its navigation 10. Glad Health at 278 Veranda St, a concierge practice, offers a weight-management membership with "first month free" language and names no GLP-1 drug and no price 11.
Astra's price is published and flat everywhere it treats: $68/month for compounded semaglutide and $118/month for compounded tirzepatide, both on 12-month plans billed annually at $816 and $1,416. That is the same number in Portland as in every other state Astra serves, with no local rate and no consult required to see it.
Portland itself carries no general-population Primary Care HPSA. Its only active designation is facility-specific: Portland Community Health Center, the city's FQHC, is designated at score 10 with an estimated 22,211 patients served, so the gap HRSA recognizes here belongs to that clinic's low-income panel rather than the general public 5.
The rest of Cumberland County is a different story. Sebago Lake SA (geographic, score 11), Porter SA (score 10), and LI-Fryeburg SA (score 16) are all active Primary Care HPSAs, and all sit in the rural western part of the county rather than in Portland 5. Maine Medical Center's Portland campus is the state's only Level I Trauma Center and its tertiary-care hub 6, which makes Portland the best in-person specialist city in Maine by a wide margin and leaves the rest of the state driving to it.
HRSA scores only primary care, dental, and mental health, so there is no numeric endocrinology figure for Portland. Telehealth matters here less for the city than for the county around it: an online visit does not require the drive into Portland. Astra serves all 50 states, including Maine.
Astra treats patients in Maine through state-licensed physicians.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. A licensed physician decides whether treatment is appropriate for you.
Monthly self-pay prices published by local providers, compared with Astra's online programs and the manufacturers' own self-pay prices for brand-name drugs. Compounded and brand-name medications are different products; compounded medications are not FDA-approved.
| Provider | Per month | Basis | Source |
|---|---|---|---|
| Cosmetic Enhancement Center of New England — semaglutide | $450 | per month, "starting at", 3-month commitment | source, checked 2026-08-28 |
| Astra — compounded semaglutide | $68 | per month, 12-month plan | program page |
| Astra — compounded tirzepatide | $118 | per month, 12-month plan | program page |
| Wegovy pen — NovoCare self-pay | $349 | per month, standard price | price index |
| Zepbound® — LillyDirect self-pay | $299–$449 | per month, by dose | price index |
Yes — online, for patients in Maine. Astra has two current promo codes:
Code
Compounded tirzepatide: code NEWSTART — $100 off. $109/mo instead of $118/mo on the 12-month plan ($1,316 billed once instead of $1,416).
Apply NEWSTART automatically →Code
Compounded semaglutide: code Sema NewStart — $30 off. Applied at checkout; plans start at $68/mo on the 12-month plan ($816 billed once) before the discount.
Apply Sema NewStart automatically →Click a button to start with the code already applied, or type the code during checkout. NEWSTART applies to the 12-month compounded tirzepatide plan. Plans are billed upfront, renew automatically and can be cancelled any time. A licensed physician decides whether treatment is appropriate; a visit does not guarantee a prescription. Compounded medications are not FDA-approved. Subscription terms · Refund policy. Last verified 2026-10-01.
All Astra promo codes · Semaglutide coupon guide · Tirzepatide coupon guide
Astra's national price is $68/mo for semaglutide and $118/mo for tirzepatide on a 12-month plan ($816/$1,416 billed annually) — the same price in every city, every dose. In Portland, cash-pay pricing is largely undisclosed: of three local providers checked, only Cosmetic Enhancement Center of New England publishes a number — a $300 enrollment plus $150/month membership, with semaglutide 'starting at $450/month' before its variable medication cost is even added. Maine Aesthetic Medicine and Glad Health publish no price at all. Against that opacity, Astra's flat $68/$118 is the one fixed, published number in the Portland market.
Not as a whole city. Portland carries no general Primary Care HPSA designation — its only HRSA flag is facility-specific, at Portland Community Health Center (score 10, ~22,211 patients served). The genuine shortage areas — Sebago Lake, Porter, and LI-Fryeburg service areas — sit in the rural western part of Cumberland County, not downtown Portland.
Maine adopted Medicaid expansion by ballot initiative in November 2017, effective January 10, 2019 (KFF). Whether MaineCare or a commercial plan covers a GLP-1 specifically for weight loss (versus a diabetes diagnosis) depends on the individual plan — there's no single statewide answer and no Portland-specific coverage figure. Astra's flat $68/mo (semaglutide) and $118/mo (tirzepatide) national pricing is designed to work as a self-pay option regardless of what a given plan covers.
Locally, Cosmetic Enhancement Center of New England, Maine Aesthetic Medicine (launching 2026), and Glad Health all offer weight-management services in Portland, though none publish a guaranteed all-in tirzepatide price. Astra offers tirzepatide by telehealth at a flat $118/mo on a 12-month plan, available to Portland residents since Astra is licensed in all 50 states.
The rest of Maine. Portland's crude adult obesity prevalence is 27.7% (2023 BRFSS cycle, CDC PLACES) versus Maine's statewide rate of 33.2% (2024 BRFSS) — about 5.5 points lower in the city. CDC PLACES doesn't publish a county-level figure, but the gap is consistent with the state's obesity burden concentrating outside Portland, including the same rural stretches of Cumberland County that HRSA separately flags as primary-care shortage areas.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.